KR101505945B1 - Functional beverage with enhanced flavor - Google Patents
Functional beverage with enhanced flavor Download PDFInfo
- Publication number
- KR101505945B1 KR101505945B1 KR1020130126180A KR20130126180A KR101505945B1 KR 101505945 B1 KR101505945 B1 KR 101505945B1 KR 1020130126180 A KR1020130126180 A KR 1020130126180A KR 20130126180 A KR20130126180 A KR 20130126180A KR 101505945 B1 KR101505945 B1 KR 101505945B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- functional beverage
- flavor
- calcium
- vitamin
- Prior art date
Links
- 239000000796 flavoring agent Substances 0.000 title claims abstract description 31
- 235000019634 flavors Nutrition 0.000 title claims abstract description 31
- 235000020510 functional beverage Nutrition 0.000 title claims abstract description 25
- 239000000284 extract Substances 0.000 claims abstract description 44
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 32
- 239000011575 calcium Substances 0.000 claims abstract description 31
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 31
- 240000005717 Dioscorea alata Species 0.000 claims abstract description 16
- 235000004879 dioscorea Nutrition 0.000 claims abstract description 16
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 claims abstract description 15
- 229940069780 barley extract Drugs 0.000 claims abstract description 14
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 13
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 claims abstract description 13
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 claims abstract description 13
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 claims abstract description 13
- 150000004676 glycans Chemical class 0.000 claims abstract description 13
- 229950006780 n-acetylglucosamine Drugs 0.000 claims abstract description 13
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 13
- 239000005017 polysaccharide Substances 0.000 claims abstract description 13
- 235000013336 milk Nutrition 0.000 claims abstract description 12
- 239000008267 milk Substances 0.000 claims abstract description 12
- 210000004080 milk Anatomy 0.000 claims abstract description 12
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims abstract description 9
- 229930003316 Vitamin D Natural products 0.000 claims abstract description 8
- 235000019166 vitamin D Nutrition 0.000 claims abstract description 8
- 239000011710 vitamin D Substances 0.000 claims abstract description 8
- 150000003710 vitamin D derivatives Chemical class 0.000 claims abstract description 8
- 229940046008 vitamin d Drugs 0.000 claims abstract description 8
- 244000068988 Glycine max Species 0.000 claims abstract description 6
- 239000000654 additive Substances 0.000 claims abstract description 4
- 230000000996 additive effect Effects 0.000 claims abstract description 4
- 229960005069 calcium Drugs 0.000 claims description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 239000008213 purified water Substances 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 11
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 241001474374 Blennius Species 0.000 claims description 3
- 244000024671 Brassica kaber Species 0.000 claims description 3
- 235000014750 Brassica kaber Nutrition 0.000 claims description 3
- 235000003599 food sweetener Nutrition 0.000 claims description 3
- 235000021579 juice concentrates Nutrition 0.000 claims description 3
- 239000003765 sweetening agent Substances 0.000 claims description 3
- 239000002535 acidifier Substances 0.000 claims description 2
- 239000004227 calcium gluconate Substances 0.000 claims description 2
- 229960004494 calcium gluconate Drugs 0.000 claims description 2
- 235000013927 calcium gluconate Nutrition 0.000 claims description 2
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims description 2
- 239000001527 calcium lactate Substances 0.000 claims description 2
- 229960002401 calcium lactate Drugs 0.000 claims description 2
- 235000011086 calcium lactate Nutrition 0.000 claims description 2
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 claims description 2
- 240000008042 Zea mays Species 0.000 abstract description 12
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000007244 Zea mays Nutrition 0.000 abstract 1
- 229940089639 cornsilk Drugs 0.000 abstract 1
- 239000001231 zea mays silk Substances 0.000 abstract 1
- 235000001465 calcium Nutrition 0.000 description 27
- 208000001132 Osteoporosis Diseases 0.000 description 12
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 11
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 11
- 235000005822 corn Nutrition 0.000 description 11
- 235000019658 bitter taste Nutrition 0.000 description 9
- 235000019640 taste Nutrition 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 229920000858 Cyclodextrin Polymers 0.000 description 5
- 102000014171 Milk Proteins Human genes 0.000 description 5
- 108010011756 Milk Proteins Proteins 0.000 description 5
- 235000013361 beverage Nutrition 0.000 description 5
- 235000021239 milk protein Nutrition 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 238000001556 precipitation Methods 0.000 description 5
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 5
- 240000005979 Hordeum vulgare Species 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 4
- 235000013376 functional food Nutrition 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- 208000006386 Bone Resorption Diseases 0.000 description 3
- 235000007340 Hordeum vulgare Nutrition 0.000 description 3
- 230000024279 bone resorption Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 108010073771 Soybean Proteins Proteins 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 229940106582 estrogenic substances Drugs 0.000 description 2
- JKKFKPJIXZFSSB-CBZIJGRNSA-N estrone 3-sulfate Chemical compound OS(=O)(=O)OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 JKKFKPJIXZFSSB-CBZIJGRNSA-N 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000011164 ossification Effects 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 229940001941 soy protein Drugs 0.000 description 2
- 235000019605 sweet taste sensations Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 244000298697 Actinidia deliciosa Species 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010006956 Calcium deficiency Diseases 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 235000002723 Dioscorea alata Nutrition 0.000 description 1
- 235000007056 Dioscorea composita Nutrition 0.000 description 1
- 235000009723 Dioscorea convolvulacea Nutrition 0.000 description 1
- 235000005362 Dioscorea floribunda Nutrition 0.000 description 1
- 235000004868 Dioscorea macrostachya Nutrition 0.000 description 1
- 235000005361 Dioscorea nummularia Nutrition 0.000 description 1
- 235000005360 Dioscorea spiculiflora Nutrition 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 235000006350 Ipomoea batatas var. batatas Nutrition 0.000 description 1
- SFBODOKJTYAUCM-UHFFFAOYSA-N Ipriflavone Chemical compound C=1C(OC(C)C)=CC=C(C2=O)C=1OC=C2C1=CC=CC=C1 SFBODOKJTYAUCM-UHFFFAOYSA-N 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 235000019738 Limestone Nutrition 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- 208000030136 Marchiafava-Bignami Disease Diseases 0.000 description 1
- 208000029725 Metabolic bone disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102000003982 Parathyroid hormone Human genes 0.000 description 1
- 108090000445 Parathyroid hormone Proteins 0.000 description 1
- 108010001441 Phosphopeptides Proteins 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 240000001987 Pyrus communis Species 0.000 description 1
- 241000269821 Scombridae Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 244000046127 Sorghum vulgare var. technicum Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000002495 Uterine Neoplasms Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- NYQLYXJSYTZDSO-FROKLYQUSA-N [Ca].CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O Chemical compound [Ca].CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O NYQLYXJSYTZDSO-FROKLYQUSA-N 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 229940069765 bean extract Drugs 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 230000004097 bone metabolism Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000005686 eating Nutrition 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 210000003278 egg shell Anatomy 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 229960005431 ipriflavone Drugs 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000006028 limestone Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 235000020640 mackerel Nutrition 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- 239000000199 parathyroid hormone Substances 0.000 description 1
- 229960001319 parathyroid hormone Drugs 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 206010046766 uterine cancer Diseases 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
Description
본 발명은 풍미가 개선된 기능성 음료에 관한 것으로서, 보다 구체적으로는 수용성 칼슘, N-아세틸글루코사민, 유염기성 단백질(Milk Basic Protein, MBP), 비타민D, 대두 다당류, 참마추출물, 옥수수수염추출물, 보리추출물, 칡추출물 및 첨가제를 적절량 사용하여 제조된 풍미가 개선된 기능성 음료에 관한 것이다.
More particularly, the present invention relates to a functional beverage having improved flavor, and more specifically, to a functional beverage having improved flavor, including water-soluble calcium, N-acetylglucosamine, Milk Basic Protein (MBP), vitamin D, soy polysaccharide, yam extract, The present invention relates to an improved flavored functional beverage prepared by using an appropriate amount of an extract, an extract, and an additive.
연령 및 성별에 따라 다소 차이는 있지만 칼슘의 영양소 기준치는 700 mg/일이며, 건강기능식품공전에 의거 칼슘을 210 ~ 800 mg/일 섭취 시 뼈와 치아 형성 및 골다공증발생 위험 감소에 도움을 줌이 명시되어 있다. 칼슘의 흡수율은 영아기에 60%로 가장 높으며 성인 여성의 평균 칼슘 흡수율은 25%로 나이를 먹어감에 따라 흡수율은 점차 감소한다.The recommended nutrient level for calcium is 700 mg / day, which is slightly different according to age and gender. The intake of calcium from 210 to 800 mg / day according to the health functional foods helps to reduce bone and tooth formation and the risk of osteoporosis. It is stated. The absorption rate of calcium is the highest at infancy (60%), and the average calcium absorption rate of adult women is 25%.
더욱이 폐경기 이후 여성의 약 30%에서 발병하는 골다공증은 가장 흔한 대사성 골질환으로 노년기 골절의 주요한 원인이 된다. 골다공증은 골형성과 골흡수 대사의 불균형으로 인하여 단위 용적당 뼈의 밀도가 감소하여 척추, 요골 및 대퇴골의 골절을 쉽게 일으키는 질병이다. 원인으로는 칼슘부족, 에스트로겐, 부갑상선 호르몬, 식사습관, 가족력 등 여러 요인에 기인한다고 한다.Furthermore, osteoporosis, which affects about 30% of women after menopause, is the most common metabolic bone disease and is the leading cause of old age fractures. Osteoporosis is a disease that easily causes fractures of the spine, radius and femur due to decreased bone density per unit dose due to unbalance of bone formation and metabolism of bone resorption. Causes include calcium deficiency, estrogen, parathyroid hormone, dietary habits, and family history.
현재 골다공증 예방 및 치료에 사용되고 있는 물질로는 칼슘제제, 인산염, 불소제제, 이소플라본(Ipriflavone), N-아세틸글루코사민, 비타민D 등이 있다. 한편, 종래 골다공증 예방 및 치료제는 대부분이 에스트로겐 계통의 물질로서 에스트로겐 계통의 물질을 장기간 복용할 경우에는 담석, 혈전증과 같은 부작용과 유방암, 자궁암과 같은 암발생 가능성이 증가한다. Currently, substances used in the prevention and treatment of osteoporosis include calcium preparations, phosphates, fluoride preparations, Ipriflavone, N-acetylglucosamine, and vitamin D. On the other hand, most of the conventional osteoporosis prevention and treatment agents are estrogenic substances, and when estrogenic substances are taken for a long time, the side effects such as gallstones and thrombosis and the likelihood of cancer such as breast cancer and uterine cancer are increased.
그러나 골다공증을 예방 빛 치료하기 위해서는 약물을 단기간 복용하는 것만으로는 효과가 없기 때문에 장기간의 복용이 필수적이다. 따라서 장기간 복용하여도 상기와 같은 부작용이 없고, 관능적으로 양호하여 섭취가 용이한 골다공증을 예방 및 치료할 수 있는 소재에 대한 연구가 진행되고 있는 실정이다. However, in order to prevent osteoporosis, it is necessary to take a long-term dose because it is not effective only by taking a drug for a short time. Therefore, researches have been conducted on materials capable of preventing and treating osteoporosis, which has no side effects as described above even when taken for a long period of time, and is sensually good and easy to ingest.
한국 등록특허 제10-0509177호는 골다골증 예방용 기능성 식품 조성물에 관한 것으로, 골다공증 예방 및 치료에 효능이 있는 것으로 알려진 이소플라본, 해조칼슘, 비타민 D3, 유단백 가수분해물(Casein Phospho Peptide, CPP)에 골 형성 촉진과 골 흡수 억제 기능을 동시에 갖는 효과와 안전성이 뛰어난 우유로부터 분리 정제된 유염기성 단백질(Milk Basic Protein, MBP)을 유효성분으로 일정 비율 함유시킴으로써, 골다공증과 이와 함께 유발되는 골절을 예방 및 치료가 가능한 조성물에 대해 개시하고 있다. 하지만 이는 유단백질에 의해 침전이 가능하여 음료 등으로 적용 시에 외관상 소비자에게 비호감을 느끼게 하고 특유의 쓴맛으로 인해 식음 시에 거부감을 느끼게 하여 널리 적용되는데 여전히 한계가 있다. Korean Patent No. 10-0509177 relates to a functional food composition for prevention of osteoporosis and relates to a functional food composition for prevention and treatment of osteoporosis wherein isoflavone, seaweed calcium, vitamin D3, and casein phosphopeptide (CPP) (Milk Basic Protein (MBP)), which is separated from milk, which has excellent safety and bone resorption inhibitory effect at the same time, to prevent and treat osteoporosis and related fractures ≪ / RTI > However, since it can be precipitated by milk protein, it can be applied widely to be applied to beverages and the like.
이에 골다공증 예방이 필요한 소비자들이 보다 쉽게 접할 수 있는 안정성 및 풍미가 우수한 기능성 음료의 제공이 필요한 실정이다.
Therefore, there is a need to provide a functional beverage having stability and flavor that can be easily accessible to consumers who need to prevent osteoporosis.
이에 본 발명자는 기능성 음료를 개발하던 중, 수용성 칼슘, N-아세틸글루코사민, 유염기성 단백질(Milk Basic Protein, MBP), 비타민D 등의 뼈 강화 기능성 물질에 대두 다당류를 포함하는 경우 유염기성 단백질이 침전되지 않으며, 참마추출물, 옥수수수염추출물, 보리추출물 및 칡추출물을 적절량 함유 시에 수용성 칼슘, N-아세틸글루코사민의 특유의 쓴 맛을 개선하게 되어 풍미가 개선되고, 육안상, 미관상 소비자에게 선호될 만한 기능성 음료를 제공할 수 있다는 것을 알게 되어 본 발명을 완성하기 이르렀다. Accordingly, the inventors of the present invention have found that when a functional beverage includes a soybean polysaccharide in a bone-reinforcing functional substance such as water-soluble calcium, N-acetylglucosamine, Milk Basic Protein (MBP) and vitamin D, And the specific bitter taste of water-soluble calcium and N-acetylglucosamine is improved when containing an appropriate amount of yam extract, corn beard extract, barley extract and 칡 extract, and the flavor is improved, and it is preferable to the naked eye and the cosmetic consumer The present invention has been completed.
따라서, 본 발명은 풍미가 개선된 기능성 음료를 제공하는 것을 발명의 목적으로 한다.
Accordingly, it is an object of the present invention to provide a functional beverage having improved flavor.
위와 같은 과제를 해결하기 위해, 본 발명은 정제수 100 mL에 대해, 수용성 칼슘 0.4 ~ 1.5 g, N-아세틸글루코사민 0.2 ~ 1.4 g, 유염기성 단백질(Milk Basic Protein, MBP) 0.01 ~ 0.1 g, 비타민D3 함량이 0.25 중량%인 비타민D3 혼합제제 0.0002 ~ 0.005 g, 대두 다당류 0.01 ~ 0.1 g, 참마추출물 0.05 ~ 3.0 g, 옥수수수염추출물 0.01 ~ 2.0 g, 보리추출물 0.01 ~ 2.0 g 및 칡추출물 0.05 ~ 3.0 g을 포함하는 풍미가 개선된 기능성 음료를 제공한다.
In order to solve the above-mentioned problems, the present invention provides a method for producing a pharmaceutical composition, which comprises administering to 100 mL of purified water, 0.4 to 1.5 g of water-soluble calcium, 0.2 to 1.4 g of N-acetylglucosamine, 0.01 to 0.1 g of Milk Basic Protein (MBP) 3 , 0.0002 to 0.005 g of a mixed vitamin D 3 preparation, 0.01 to 0.1 g of soy polysaccharide, 0.05 to 3.0 g of yam extract, 0.01 to 2.0 g of corn mustard extract, 0.01 to 2.0 g of barley extract, 3.0 g of a flavored functional drink.
본 발명에 따른 기능성 음료는 참마, 옥수수, 보리, 칡의 특유의 향이 개선된 풍미를 제공하여 식음 시에 거부감을 해소시킬 수 있다. The functional beverage according to the present invention can provide an improved flavor of yam, corn, barley, and mackerel, thereby relieving the feeling of rejection at the time of eating.
삭제delete
또한 대두 다당류가 유염기성 단백질(Milk Basic Protein, MBP)의 침전을 개선하기에 안정성이 우수한 음료를 제공할 수 있다.
Also, soybean polysaccharides can provide stable beverages to improve precipitation of Milk Basic Protein (MBP).
도 1은 비교예 1(a), 비교예 2(b) 및 실시예 1(c)의 기능성 음료의 외관을 나타낸 사진이다.1 is a photograph showing the appearance of functional beverages of Comparative Examples 1 (a), 2 (b) and 1 (c).
이하에서 본 발명을 하나의 구현예로서 보다 상세히 설명한다. Hereinafter, the present invention will be described in more detail as an embodiment.
본 발명은 정제수 100 mL에 대해 수용성 칼슘 0.4 ~ 1.5 g, N-아세틸글루코사민 0.2 ~ 1.4 g, 유염기성 단백질(Milk Basic Protein, MBP) 0.01 ~ 0.1 g, 비타민D3 함량이 0.25 중량%인 비타민D3 혼합제제 0.0002 ~ 0.005 g, 대두 다당류 0.01 ~ 0.1 g, 참마추출물 0.05 ~ 3.0 g, 옥수수수염추출물 0.01 ~ 2.0 g, 보리추출물 0.01 ~ 2.0 g 및 칡추출물 0.05 ~ 3.0 g를 포함하는 기능성 음료이다.
The present invention is a water-soluble calcium 0.4 ~ 1.5 g, N- acetylglucosamine 0.2 ~ 1.4 for the 100 mL purified water, g, u basic protein (Milk Basic Protein, MBP) 0.01 ~ 0.1 g, of vitamin D 3 content of 0.25% by weight of vitamin D 3 is a functional drink containing 0.0002 to 0.005 g of a mixed preparation, 0.01 to 0.1 g of a soy polysaccharide, 0.05 to 3.0 g of a yam extract, 0.01 to 2.0 g of a corn mustard extract, 0.01 to 2.0 g of a barley extract and 0.05 to 3.0 g of an extract.
구체적으로 본 발명에서 사용되는 수용성 칼슘은 체내 흡수율이 높고, 소화에 무리를 주지 않으나 특유의 쓴맛을 갖는 특징이 있다. 한편 수용성 칼슘 중 탄산칼슘은 석회석, 조개껍질, 달걀껍질 등에서 추출하며 칼슘의 함량이 높지만 상대적으로 흡수율이 낮고 소화가 잘 되지 않는 문제점이 있다. 이에 본 발명에서는 젖산칼슘, 글루콘산칼슘 및 해조칼슘로 이루어진 군으로부터 선택된 1종 이상의 칼슘을 포함하는 것이 바람직하다. Specifically, the water-soluble calcium used in the present invention has a high absorption rate in the body and does not cause any difficulty in digestion but has a characteristic bitter taste. On the other hand, calcium carbonate in water-soluble calcium is extracted from limestone, shell shell and egg shell, and has a high content of calcium but has a relatively low water absorption rate and poor digestion. Accordingly, the present invention preferably includes at least one calcium selected from the group consisting of calcium lactate, calcium gluconate, and seaweed calcium.
아울러, 본 발명에서는 정제수 100 mL에 대해 수용성 칼슘 0.4 ~ 1.5 g을 사용하는 것이 바람직하며, 수용성 칼슘을 1.5 g 초과 사용할 경우 일부 칼슘이 석출되어 침전되는 문제가 발생할 수 있기 때문이다.In addition, in the present invention, 0.4-1.5 g of water-soluble calcium is preferably used per 100 mL of purified water. When the water-soluble calcium is used in excess of 1.5 g, some calcium may precipitate and precipitate.
상기 N-아세틸글루코사민은 새우나 게 등 갑각류의 껍질을 구성하는 성분인 키틴을 가수분해하여 얻어지는 물질로서, 체내에서는 세포와 세포의 결합 성분, 점막 성분, 관절 윤활액 등의 성분인 글루코사미노글리칸, 당지질, 당 단백 등을 구성하는 물질이다. 본 발명에서는 N-아세틸글루코사민을 0.2 ~ 1.4 g 사용하는 것이 바람직하며, N-아세틸글루코사민을 1.4 g 초과 사용하는 경우 건강기능식품공전에서 제시하는 일일섭취량이 초과될 수 있는 문제가 발생할 수 있다.The N-acetylglucosamine is a substance obtained by hydrolyzing chitin which is a component constituting the shell of shrimp and crab crustaceans. In the body, N-acetylglucosamine is a glucosaminoglycan, which is a component of cells and cell binding components, mucosal components, , Glycolipids, and glycoproteins. In the present invention, it is preferable to use N-acetylglucosamine in an amount of 0.2 to 1.4 g. When N-acetylglucosamine is used in an amount of more than 1.4 g, the daily intake of the health functional food may be exceeded.
상기 유염기성 단백질(Milk Basic Protein, MBP)은 유장 단백질(Whey protein)에서 이온교환수지를 통해 얻어지며 카제인 보다 리신과 아르기닌 함량이 높아 염기성을 띤다. 이 염기성 단백질은 골아세포(Osteoblast)에 의한 골형성을 촉진시킬 뿐만 아니라 파골세포(Osteoclast)에 의한 골흡수를 억제하는 기능을 동시에 갖는다. Milk Basic Protein (MBP) is obtained from whey protein through an ion exchange resin. It has a higher content of lysine and arginine than casein and is basic. This basic protein not only promotes bone formation by osteoblasts but also has the function of inhibiting bone resorption by osteoclasts.
이에 본 발명에서는 유염기성 단백질을 0.01 ~ 0.1 g을 사용하는 것이 바람직하며, 유염기성 단백질을 0.1 g 초과 사용하는 경우 점성이 높아져 식감이 나빠지는 문제가 있기에 상기 범위 내의 농도를 갖는 단백질을 사용하는 것이 좋다.Therefore, in the present invention, it is preferable to use 0.01 to 0.1 g of a glutinous protein, and when the glutinous protein is used in an amount of more than 0.1 g, the viscosity tends to increase and the texture of the glutinous protein tends to deteriorate. Therefore, good.
한편 우유 단백질은 pH에 민감하여 등전점인 pH인 4.6에 근접하면 단백질 분자가 서로 응집되어, 병의 밑바닥에 침전되거나 유분리를 일으키게 된다. 하지만 상온 유통의 액상 제품 특성상 미생물 안정성을 위해 제품 pH를 최소 3.8 이하로 유지해야 하며, 이는 우유 단백질의 침전을 일으킬 수 있다. On the other hand, milk protein is sensitive to pH, so protein molecules will flocculate and precipitate at the bottom of the bottle or cause oil separation when the pH is near 4.6, the isoelectric point. However, due to the characteristics of the liquid product at room temperature circulation, the product pH should be maintained at a minimum of 3.8 or less for microbial stability, which may cause precipitation of milk protein.
본 발명에서는 대두 다당류를 사용하여 칼슘과 우유 단백질의 침전을 제어하고, 음료에 바디감을 부여하며 약간의 감미가 있어 전체적인 풍미를 부드럽게 하고 쓴맛 성분을 저하시킬 수 있는 시클로덱스트린 분말을 사용하는 것이 바람직하다. 하지만 반드시 이에 한정되는 것은 아니다.In the present invention, it is preferable to use a soybean polysaccharide to control the precipitation of calcium and milk proteins, to impart a body sensation to the beverage, and to have a slight sweetness, thereby softening the overall flavor and lowering the bitter taste component . However, it is not necessarily limited thereto.
따라서 대두 다당류 0.01 ~ 0.1 g를 사용하는 것이 바람직하고, 더욱 바람직하게는 0.03 ~ 0.07 g을 사용한다. 특히 대두 다당류가 0.01 g 미만인 경우 침전 억제 효과가 저하되고, 0.1 g 초과인 경우 식감이 저하되기에 상기 범위 내에서 사용하는 것이 좋다. 또한 대두 다당류, 유염기성 단백질 및 수용성 칼슘은 다른 원료들에 의한 간섭을 줄이고, 침전 방지 효과를 높이기 위해 이들 원료만 따로 혼합하여 40 ~ 50℃ 온수에 넣어 교반하여 용해 후 10분 정도 안정화 시킨 후 사용하는 것이 좋다. Therefore, it is preferable to use 0.01 to 0.1 g of soy polysaccharide, more preferably 0.03 to 0.07 g. Particularly, when the soy polysaccharide is less than 0.01 g, the effect of inhibiting the precipitation is lowered. If the soy polysaccharide is more than 0.1 g, the texture is lowered. In addition, soybean polysaccharide, glutinous protein and water-soluble calcium are mixed separately in 40 ~ 50 ℃ hot water to stabilize for 10 minutes after dissolving, to reduce interference by other ingredients and to prevent precipitation. It is good to do.
그리고 본 발명에서 비타민 D는 혈중 칼슘과 인의 수준을 정상 범위로 조절하고 평형을 유지시킨다. 또한 비타민 D는 칼슘의 기능 유지에 도움을 주며 신경과 근육의 이음부의 기능을 유지하기 위해 칼슘을 충분히 공급할 뿐 아니라, 뼈의 주요 성분인 인산칼슘을 만들기 위해 칼슘 뿐만 아니라 인의 사용도 조절한다. In the present invention, vitamin D regulates blood levels of calcium and phosphorus to a normal range and maintains equilibrium. Vitamin D also helps to maintain calcium function, not only provides enough calcium to maintain the function of nerve and muscle joints, but also regulates the use of calcium as well as phosphorus to make calcium phosphate, a major component of bone.
이에 본 발명에서는 비타민D3 함량이 0.25 중량%인 비타민D3 혼합제제0.0002 ~ 0.005 g을 사용하는 것이 바람직하며, 비타민D3 혼합제제를 0.005 g 초과 사용할 경우 일일섭취량이 초과될 수 있는 문제가 발생하기에 상기 범위 내에서 사용하는 것이 바람직하다.Therefore, in this invention it is preferred to use a vitamin D 3 content of 0.25% by weight of vitamin D 3 Mixed formulations 0.0002 ~ 0.005 g, the problem that the daily intake can be exceeded when this is 0.005 g excess use of vitamin D 3 Mixed formulations occurs It is preferable to use it within the above-mentioned range.
또한 상기 참마추출물에서 참마는 뿌리는 식용하며, 저열량 저지방 식품으로 다이어트에 탁월하며 강장효과가 뛰어나다. 또한 쓴맛이 적고 옅은 단맛을 갖는다. 이에 본 발명에서는 참마추출물 0.05 ~ 3.0 g을 사용하는 것이 바람직하다. 참마추출물이 0.05 g 미만인 경우 풍미 개선 효과가 적고, 3.0 g 초과인 경우 전체적인 풍미의 조화도가 저하되는 문제가 있기에 상기 범위 내에서 사용한다.In addition, the yam is an edible root of the yam, low-calorie low-fat food, excellent in diet and excellent tonic effect. It also has a bitter taste and a light sweet taste. Therefore, it is preferable to use 0.05 to 3.0 g of yam extract in the present invention. When the yamme extract is less than 0.05 g, the effect of improving the flavor is small. When the yamme extract is more than 3.0 g, the harmony of the overall flavor is lowered.
상기 옥수수수염추출물은 폴리페놀과 플라보노이드 성분이 많아 신장 질환, 당뇨, 고혈압 등에 좋으며 강한 이뇨작용이 있으며, 옥수수 특유의 구수한 맛이 난다. 이에 본 발명에서는 옥수수수염추출물이 0.01 ~ 2.0 g인 것을 사용하는 것이 바람직하다. 옥수수수염추출물이 0.01 g 미만인 경우 풍미 개선 효과가 적고, 2.0 g 초과인 경우 옥수수 특유의 풍미가 강해져 전체적인 풍미의 조화도가 저하되는 문제가 발생하기에 상기 범위 내에서 사용하는 것이 좋다.The corn mustache extract is rich in polyphenols and flavonoids, which is good for kidney disease, diabetes, hypertension, strong diuretic effect, and has a unique taste of corn. In the present invention, it is preferable to use a cornstarch extract of 0.01 to 2.0 g. When the amount of the extract of corn musth is less than 0.01 g, the effect of improving the flavor is small. When the content exceeds 2.0 g, the flavor peculiar to corn becomes strong and the harmony of the whole flavor is lowered.
상기 보리추출물은 다른 맥류에 비해 탄수화물의 함량이 높고 무기질과 비타민 B군이 풍부하며, 식이섬유가 풍부하여 변비 및 혈당 저하, 고혈압 등에 효과가 있고 풍미가 구수하다. 이에 본 발명에서는 보리추출물이 0.01 ~ 2.0 g인 것을 사용하는 것이 바람직하다. 보리추출물이 0.01 g 미만인 경우 풍미 개선 효과가 적고, 2.0 g 초과인 경우 보리 특유의 풍미가 올라와 전체적인 풍미를 저하시키고 제품 색을 어둡게 변화시키는 문제가 있기에 상기 범위 내에서 사용하는 것이 좋다.The barley extract has a higher carbohydrate content than the other pulses, rich in minerals and vitamin B groups, and rich in dietary fiber, which is effective for constipation, hypoglycemia, hypertension and the like. Therefore, in the present invention, it is preferable to use 0.01 to 2.0 g of the barley extract. When the barley extract is less than 0.01 g, the effect of improving the flavor is small. When the barley extract is more than 2.0 g, the flavor peculiar to the barley is increased to lower the overall flavor and darken the product color.
상기 칡추출물은 골다공증, 숙취해소, 혈액순환 등의 효능이 있으며 옅은 단맛과 약간의 쌉싸름한 맛을 가지고 있다. 이에 본 발명에서는 칡추출물이 0.05 ~ 3.0 g인 것을 사용하는 것이 바람직하다. 칡추출물이 0.05 g 미만인 경우 풍미 개선 효과가 적고, 3.0 g 초과인 경우 오히려 쓴맛이 강해져 풍미가 저하되는 문제가 있기에 상기 범위 내에서 사용하는 것이 좋다.The above extract has an efficacy of osteoporosis, hangover resolution, blood circulation, etc., and has a light sweet taste and a slightly bland taste. Therefore, in the present invention, it is preferable to use 0.05-3.0 g of Lycopersicon esculentum extract. If the extract is less than 0.05 g, the effect of improving the flavor is small. If the extract is more than 3.0 g, the bitterness is rather strong and the flavor is lowered.
아울러 상기 추출물은 각 추출 대상의 중량 대비 5 ~ 15 배량의 정제수에 첨가하고 80 ~ 120℃의 온도에서 최초 정제수의 부피 대비 5 ~ 50%가 될 때까지 추출할 수 있다. 상기의 추출물은 농축 상태 또는 분말 형태로 사용할 수 있다.The extract may be added to purified water of 5 to 15 times the weight of each extraction target and extracted at a temperature of 80 to 120 ° C until the volume of the purified water becomes 5 to 50% of the initial purified water. The extract can be used in concentrated or powder form.
또한 본 발명에 따른 기능성 음료는 정제수 100 mL에 대해 감미료 0.5 ~ 10.0 g, 산미료 0.1 ~ 5.0 g, 과즙 농축액 0.01 ~ 10.0 g, 시클로텍스트린 분말 0.1 ~ 1.0 g 및 혼합과일향 0.01 ~ 1.0 g 로 이루어진 군으로부터 선택된 1종 이상의 첨가제를 더 포함할 수 있다. The functional beverage according to the present invention is prepared by mixing 0.5 to 10.0 g of a sweetener, 0.1 to 5.0 g of an acidifier, 0.01 to 10.0 g of a juice concentrate, 0.1 to 1.0 g of a cyclotrisin powder, and 0.01 to 1.0 g of a mixture, Lt; RTI ID = 0.0 > additive < / RTI >
상기 감미제는 백설탕, 액상과당, 또는 결정 과당 중에서 선택된 1종 이상을 포함하여 사용할 수 있다. 또한 산미료는 구연산, 사고나산, 아스코르빈산, 주석산, 젖산 및 푸마르산으로 이루어진 군으로부터 선택된 1종 이상을 포함하여 사용할 수 있다. The sweetener may be at least one selected from white sugar, liquid fructose, and crystalline fructose. The acidulant may be at least one selected from the group consisting of citric acid, silicic acid, ascorbic acid, tartaric acid, lactic acid and fumaric acid.
상기 과즙 농축액은 사과, 배, 포도, 복숭아, 키위, 멜론, 오렌지, 귤, 알로에, 딸기 및 베리류로 이루어진 군으로부터 선택된 1종 이상의 과즙을 포함할 수 있다. The juice concentrate may include at least one juice selected from the group consisting of apple, pear, grape, peach, kiwi, melon, orange, mandarin, aloe, strawberry and berries.
상기 시클로덱스트린 분말은 0.1 ~ 1.0 g로 포함하며, 더욱 바람직하게는 0.3 ~ 0.7 g이다. 시클로덱스트린 분말이 0.1 g 미만인 경우 바디감 부여 및 쓴맛 저하 효과가 낮고, 1.0 g 초과인 경우 시클로덱스트린 분말 특유의 풍미가 강해져 음료 전체의 관능을 저하시키기 때문에 상기 범위 내에서 사용하는 것이 좋다.The cyclodextrin powder is contained in an amount of 0.1 to 1.0 g, more preferably 0.3 to 0.7 g. When the amount of the cyclodextrin powder is less than 0.1 g, the effect of imparting a body sensation and bitter taste is low. When the amount of the cyclodextrin powder is more than 1.0 g, the flavor inherent in the cyclodextrin powder is intensified to lower the overall sensibility of the beverage.
다시 말해 본 발명에 따른 각각의 조성물은 수용성 칼슘, N-아세틸글루코사민, 유염기성 단백질(Milk Basic Protein, MBP), 비타민D, 대두 다당류, 참마추출물, 옥수수수염추출물, 보리추출물, 칡추출물 및 첨가제를 적절량 사용하여 풍미가 개선된 기능성 음료를 제공할 수 있는 것이다.
In other words, each of the compositions according to the present invention can be used in combination with water-soluble calcium, N-acetylglucosamine, Milk Basic Protein (MBP), vitamin D, soy polysaccharide, yam extract, corn bean extract, barley extract, It is possible to provide a functional beverage having improved flavor using an appropriate amount.
이하, 본 발명을 실시예를 통하여 더욱 상세히 설명한다. 그러나 이들 실시예는 본 발명을 예시하기 위한 것으로, 본 발명의 범위가 이들에 의해 한정되는 것은 아니다.
Hereinafter, the present invention will be described in more detail with reference to examples. However, these examples are for illustrating the present invention, and the scope of the present invention is not limited thereto.
제조예Manufacturing example : 추출물의 제조: Preparation of extract
A. A. 참마추출물Yam extract
참마를 세척한 후 물기를 제거하고 절단한다. 참마 중량 대비 10 배의 정제수를 첨가하고 50℃에서 4 시간 동안 가열 및 추출한다. 착즙기로 착즙 후 여과포로 여과하여 참마추출물을 제조한다.
After washing the yam, remove the water and cut it. 10 times more purified water than yam is added and heated and extracted at 50 ℃ for 4 hours. After the juice is squeezed with a juicer, it is filtered with a filter cloth to prepare a yam extract.
B. 옥수수수염추출물B. Corn Beard Extract
옥수수수염 중량 대비 10 배의 정제수를 첨가하고 95℃에서 5 시간 동안 가열 및 추출한다. 냉각 후 규조토 여과하여 옥수수수염추출물을 제조한다.
10 times as much purified water as the weight of corn beard is added and heated and extracted at 95 ° C for 5 hours. After cooling, diatomaceous earth is filtered to prepare corn mustache extract.
C. 보리추출물 C. barley extract
보리를 분쇄 후 10 배의 정제수를 첨가하고 95℃에서 30 분 동안 가열 및 추출한다. 착즙기로 착즙 후 여과포로 여과하여 보리추출물을 제조한다.
The barley is pulverized, then 10 times of purified water is added, and the mixture is heated and extracted at 95 DEG C for 30 minutes. After the juice is squeezed with a juicer, it is filtered with a filter cloth to prepare a barley extract.
D. D. 칡추출물칡 extract
칡 중량 대비 10 배의 정제수를 첨가하고 95℃에서 30 분 동안 가열 및 추출한다. 착즙기로 착즙 후 여과포로 여과하여 칡추출물을 제조한다.
Add 10 times the weight of purified water and heat and extract at 95 ° C for 30 minutes. After the juice is squeezed with a juicer, it is filtered with a filter cloth to prepare an extract.
비교예Comparative Example 1 ~ 2 및 1 to 2 and 실시예Example 1 ~ 6 1 to 6
하기 표 1에 기재된 조성과 함량에 따라 기능성 음료를 제조하였다.Functional beverages were prepared according to the compositions and contents shown in Table 1 below.
추출물yam
extract
추출물barley
extract
추출물칡
extract
덱스트린Cyclo
dextrin
실험예Experimental Example 1: 관능검사 1: Sensory evaluation
1) 실험재료1) Experimental material
비교예 1 ~ 2 및 실시예 1 ~ 6에서 제조한 기능성 음료를 준비하였다. The functional beverages prepared in Comparative Examples 1 to 2 and Examples 1 to 6 were prepared.
2) 실험방법2) Experimental method
20 명의 패널요원을 선정하여 관능검사를 수행하였다. 관능검사에서 쓴맛 강도, 맛, 향, 선호도, 구매의사에 대한 평가는 9점 척도법을 사용하였으며, 그 결과는 하기 표 2에 나타낸 바와 같다. 검사 항목 수치는 패널의 점수 총합을 패널수로 나눈 후 소수 둘째 자리에서 반올림한 것으로 수치가 높을수록 관능성이 우수함을 의미한다. Twenty panelists were selected for sensory evaluation. The bitterness intensity, taste, flavor, preference, and willingness to buy were determined by the 9-point scale method in the sensory test, and the results are shown in Table 2 below. The number of test items means that the total score of the panel is divided by the number of panels and then rounded up to the second decimal place. The higher the numerical value, the better the sensuality.
표 2에 나타낸 바와 같이 본 발명 따른 실시예 1 ~ 6의 기능성 음료는 쓴맛 강도가 저하되고 맛, 향 등의 관능적인 풍미가 우수하였다. 구체적으로 각 추출물들을 2.0 g로 사용 시에 쓴맛 강도가 가장 크게 감소하였지만, 맛 및 향 등의 풍미와 선호도는 다소 감소함을 알 수 있었다. 그 중에서도 참마추출물 0.5 g, 옥수수수염추출물 1.0 g, 보리추출물 1.0 g, 칡추출물 1.0 g가 포함된 실시예 2의 기능성 음료는 쓴맛을 최소화시키고 전체적인 풍미 및 선호도가 가장 우수한 것으로 보아 음료 풍미 개선에 효과적으로 작용하여 상품가치가 향상되었음을 알 수 있었다.As shown in Table 2, the functional beverages of Examples 1 to 6 according to the present invention had a deteriorated bitter strength and excellent sensory tastes such as taste and aroma. Specifically, when the extracts were used at 2.0 g, the bitterness intensity was the greatest decrease, but the flavor and flavor such as taste and flavor decreased somewhat. Among them, the functional beverage of Example 2 containing 0.5 g of yam extract, 1.0 g of corn beard extract, 1.0 g of barley extract and 1.0 g of bamboo extract has the best bitter taste and the best overall flavor and preference, It was found that the product value was improved.
아울러 도 1은 비교예 1(a) 및 비교예 2(b), 실시예 1(c)의 기능성 음료의 외관을 나타낸 사진이다. 비교예 1(a)는 칼슘과 유염기성 단백질로 인해 음료 바닥 부분에 침전물이 형성되어 시각적 평가가 낮았고, 비교예 2(b) 및 실시예 1(c)의 경우 침전물이 형성되지 않고 균일한 성상을 확인할 수 있었다. 1 is a photograph showing the appearance of the functional beverage of Comparative Example 1 (a), Comparative Example 2 (b), and Example 1 (c). Comparative Example 1 (a) showed a low visual evaluation due to the formation of precipitates in the bottom portion of the beverage due to calcium and an opaque protein. In Comparative Example 2 (b) and Example 1 (c), no precipitate was formed, .
따라서 상기 시각적 평가와 도 1에 나타낸 바와 같이, 대두 단백질을 혼합하는 경우 칼슘과 유염기성 단백질(Milk Basic Protein, MBP)에 의한 침전이 억제되기에, 미관상 개선되어 소비자의 구매 의사가 높아지고 상품 가치가 향상되었음을 알 수 있었다. Therefore, as shown in FIG. 1, when the soy protein is mixed with calcium and milk protein (Milk Basic Protein, MBP), the taste is improved and the taste is improved. .
Claims (3)
For purified water, 100 mL, 0.4 ~ 1.5 g Water-soluble calcium, N- acetylglucosamine 0.2 ~ 1.4 g, oil basic protein (Milk Basic Protein, MBP) 0.01 ~ 0.1 g, of vitamin D, vitamin D 3 content of 0.25 3% by weight mixture Wherein the flavor is characterized by comprising 0.0002 to 0.005 g of the preparation, 0.01 to 0.1 g of soybean polysaccharide, 0.05 to 3.0 g of yam extract, 0.01 to 2.0 g of corn mustard extract, 0.01 to 2.0 g of barley extract and 0.05 to 3.0 g of 가 extract Improved functional beverage.
2. The flavor-improving functional beverage according to claim 1, wherein the water-soluble calcium comprises at least one member selected from the group consisting of calcium lactate, calcium gluconate, and seaweed calcium.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020130126180A KR101505945B1 (en) | 2013-10-22 | 2013-10-22 | Functional beverage with enhanced flavor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020130126180A KR101505945B1 (en) | 2013-10-22 | 2013-10-22 | Functional beverage with enhanced flavor |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101505945B1 true KR101505945B1 (en) | 2015-03-25 |
Family
ID=53028575
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020130126180A KR101505945B1 (en) | 2013-10-22 | 2013-10-22 | Functional beverage with enhanced flavor |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101505945B1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040071349A (en) * | 2003-02-05 | 2004-08-12 | 롯데제과주식회사 | Composition of functional food for prevention and treatment of osteoporosis |
KR20070098852A (en) * | 2004-12-20 | 2007-10-05 | 오가와코료 가부시키가이샤 | Additive for carbonated beverage |
KR20080102059A (en) * | 2007-05-18 | 2008-11-24 | (주)엔돌핀에프앤비 | Method for development of tea bag using corn and corn silk |
JP5307019B2 (en) * | 2007-09-27 | 2013-10-02 | サッポロビール株式会社 | Bone resorption inhibitor and beverages, foods and pharmaceuticals containing the same |
-
2013
- 2013-10-22 KR KR1020130126180A patent/KR101505945B1/en active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040071349A (en) * | 2003-02-05 | 2004-08-12 | 롯데제과주식회사 | Composition of functional food for prevention and treatment of osteoporosis |
KR20070098852A (en) * | 2004-12-20 | 2007-10-05 | 오가와코료 가부시키가이샤 | Additive for carbonated beverage |
KR20080102059A (en) * | 2007-05-18 | 2008-11-24 | (주)엔돌핀에프앤비 | Method for development of tea bag using corn and corn silk |
JP5307019B2 (en) * | 2007-09-27 | 2013-10-02 | サッポロビール株式会社 | Bone resorption inhibitor and beverages, foods and pharmaceuticals containing the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU782748B2 (en) | Calcium/calcium-magnesium fortified water, juices, beverages and other liquid food products | |
KR101036883B1 (en) | Health beverage composition comprising Swellfish extracts and preparation method thereof | |
CN102858192A (en) | Protein recovery beverage | |
WO2005056477A2 (en) | Stable sodium-free or low-sodium aqueous solution of agreeable saltiness taste | |
JP2013247872A (en) | Olive jelly food | |
CN104106825B (en) | The preparation method of fruit vinegar beverage | |
CN107252024A (en) | A kind of matrimony vine sea buckthorn juice and preparation method thereof | |
KR100759222B1 (en) | Method for preparing a drink with red ginseng and vinegar | |
EP3541201B1 (en) | Taste improvement for stevia sweetened beverages with miracle fruit | |
CN104738781A (en) | Novel black corn bitter herb beverage preparation method and product thereof | |
CN106136218A (en) | A kind of preparation method of Se-enriched Icing Sugar | |
CN103478520A (en) | Compound fruit jam and production technique thereof | |
CN104432308A (en) | Health Chinese yam and rice compound beverage and preparation method thereof | |
RU2612779C2 (en) | Beverage concentrate (versions) | |
CN103988911A (en) | Black potato buffalo milk dairy product and preparation method thereof | |
KR100851152B1 (en) | Beverage composition including chicken breast fresh | |
KR20130005978A (en) | Composition of fruits and vegetables beverage containing fig and the method thereof | |
CN104413238A (en) | Preserved clausena lansium throat sugar | |
KR101505945B1 (en) | Functional beverage with enhanced flavor | |
JPH02154673A (en) | Production of beverage containing water-soluble dietary fiber | |
CN110419655A (en) | A kind of Hawthorn Juice Beverages and its production technology | |
KR102410710B1 (en) | Method for manufacturing soy source steamed chicken | |
RU2365290C1 (en) | Mayonnaise mustard-protein sauce preparation method | |
CN112120083B (en) | Ginkgo fruit and citron dew and preparation method thereof | |
CN103932331B (en) | A kind of take raspberry as functional health beverage of main component and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
FPAY | Annual fee payment |
Payment date: 20180206 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20190227 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20200218 Year of fee payment: 6 |